The involvement of G proteins and regulators of receptor-G protein coupling in the pathophysiology, diagnosis and treatment of mood disorders

Clinica Chimica Acta

Volumn 366, Issue 1-2, 2006, Pages 37-47

  Avissar, Sofia ^a   Schreiber, Gabriel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Antidepressant; Beta arrestin; G protein; G protein coupled kinase (GRK); Mood disorder; Mood stabilizer

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BETA ARRESTIN; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; IMIPRAMINE; IPRONIAZID; LITHIUM; MAPROTILINE; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; NORTRIPTYLINE; RESERPINE; RETINA S ANTIGEN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

BIPOLAR DISORDER; CHEMICAL ANALYSIS; COMORBIDITY; DEPRESSION; DESENSITIZATION; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC TEST; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; ENZYME ACTIVITY; GENETIC SUSCEPTIBILITY; GENOMICS; HUMAN; HYPOTHESIS; MAJOR DEPRESSION; MANIA; MENTAL DISEASE; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; PSYCHOPHARMACOLOGY; QUANTITATIVE TRAIT LOCUS; RECEPTOR DOWN REGULATION; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; STANDARDIZATION;

ANIMALS; ARRESTINS; GTP-BINDING PROTEINS; HUMANS; MODELS, BIOLOGICAL; MOOD DISORDERS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 33644701218     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.11.003     Document Type: Review

References (109)

1. J.F.J. Cade Lithium salts in the treatment of psychotic excitement Med J Australia 36 1949 349 352
2. J. Delay, and P. Deniker Le traitement des psychoses par une methode neurolytique derive de l'hibernotherapie Neurol France 50 1952 451 497
3. R. Kuhn The treatment of depressive states with an iminodibenzyl derivative (G 22355) Swiss Med J 87 1957 1135 1140
4. H.P. Loomer, J.C. Saunders, and N.S. Kline A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer Psychiatr Res Rep 8 1957 129 134
5. I. Creese, D.R. Burt, and S.H. Snyder Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs Science 192 1976 481 483
6. P. Seeman, T. Lee, M. Chau-Wong, and K. Wong Antipsychotic drug doses and neuroleptic dopamine receptors Nature 261 1976 717 719
7. J.J. Schildkraut The catecholamine hypothesis of affective disorders Am J Psychiatry 122 1965 509 522
8. A. Coppen The biochemistry of affective disorders Brit J Psychiatry 113 1967 1237 1264
9. I.P. Lapin, and G.F. Oxenkrug Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect Lancet 1 1969 132 136
10. A.J. Prange Jr., I.C. Wilson, C.W. Lynn, L.B. Alltop, and R.A. Stikeleather l-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders Arch Gen Psychiatry 30 1974 56 62
11. D.S. Janowsky, M.K. el-Yousef, J.M. Davis, and H.J. Sekerke A cholinergic-adrenergic hypothesis of mania and depression Lancet 2 1972 632 635
12. L.J. Siever, and K.L. Davis Overview: toward a dysregulation hypothesis of depression Am J Psychiatry 142 1985 1017 1031
13. S. Avissar, and G. Schreiber Towards molecular diagnostics of mood disorders in psychiatry Trends Mol Med 8 2002 294 300
14. S. Avissar, G. Schreiber, A. Danon, and R.H. Belmaker Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex Nature 331 1988 440 442
15. S. Avissar, and G. Schreiber Muscarinic receptor subclassification and G proteins: significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neuroleptics Biol Psychiatry 26 1989 113 130 [Bennett Award Paper]
16. S. Avissar, D.L. Murphy, and G. Schreiber Magnesium reverses lithium inhibition of beta adrenergic and muscarinic receptor coupling to G proteins Biochem Pharmacol 33 1991 171 175
17. P.P. Li, Y.K. Tam, and L.T. Young Lithium decreases Gs, Gi-1, Gi-2 α subunit mRNA levels in rat cortex Eur J Pharmacol (Mol Pharmacol) 206 1991 165 166
18. S.F. Colin, H.C. Chang, and S. Mollner Chronic lithium regulates the expression of adenylate cyclase and Gi protein a subunit in rat cerebral cortex Proc Natl Acad Sci U S A 88 1991 10,634 10,637
19. S. McGowan, S.L. Eastwood, and A. Mead Hippocampal and cortical G protein (Gs alpha, Go alpha and Gi2 alpha) mRNA expression after electroconvulsive shock or lithium carbonate treatment Eur J Pharmacol 306 1996 249 255
20. S.N. Jakobsen, and O. Wiborg Selective effects of long-term lithium and carbamazepine administration on G-protein subunit expression in rat brain Brain Res 780 1998 46 55
21. H.Y. Wang, and E. Friedman Effects of lithium on receptor-mediated activation of G proteins in rat brain cortical membranes Neuropharmacology 38 1999 403 414
22. N. Minadeo, B. Layden, and L.V. Amari Effect of Li+ upon the Mg2+-dependent activation of recombinant Gialpha1 Arch Biochem Biophys 388 2001 7 12
23. C. Srinivasan, J. Toon, and L. Amai Competition between lithium and magnesium ions for the G-protein transducin in the guanosine 5′-diphosphate bound conformation J Inorg Biochem 98 2004 691 701
24. G. Schreiber, and S. Avissar Application of G proteins in the molecular diagnosis of psychiatric disorders Exp Rev Mol Diagn 3 2003 89 100
25. R.S. Williams, and A.J. Harwod Lithium therapy and signal transduction Trends Pharmacol Sci 21 2000 61 64
26. R.S. Jope Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes Trends Pharmacol Sci 24 2003 441 443
27. S.P. Banerjee, and LS. Kung Development of beta-adrenergic receptor subsensitivity by antidepressants Nature 268 1977 455 456
28. S.J. Peroutka, and S.H. Snyder Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding Science 210 1980 88 90
29. U.E. Honegger, B. Disler, and U.N. Wiesmann Chronic exposure of human cells in culture to the tricyclic antidepressant desipramine reduces the number of beta-adrenoceptors Biochem Pharmacol 35 1986 1899 1902
30. P.H. Fishman, and J.P. Finberg Effect of the tricyclic antidepressant desipramine on beta-adrenergic receptors in cultured rat glioma C6 cells J Neurochem 49 1987 282 289
31. J. Vetulani, and F. Sulser Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain Nature 257 1975 495 496
32. R.J. Baldessarini Current status of antidepressants: clinical pharmacology and therapy J Clin Psychiatry 50 1989 117 126
33. B.B. Wolfe, T.K. Harden, J.R. Sporn, and P.B. Molinoff Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants J Pharmacol Exp Ther 207 1978 446 457
34. U. Kientsch, S. Burgi, C. Ruedeberg, S. Probst, and U.E. Honegger St. John's wort extract Ze 117 (Hypericum perforatum) inhibits norepinephrine and serotonin uptake into rat brain slices and reduces 3-adrenoceptor numbers on cultured rat brain cells Pharmacopsychiatry 34 2001 56 60
35. D.B. Menkes, M.M. Rasenick, M.A. Wheeler, and M.W. Bitensky GTP activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment Science 219 1983 65 67
36. H. Ozawa, and M.M. Rasenick Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment Mol Pharmacol 36 1989 803 808
37. H. Ozawa, and M.M. Rasenick Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs J Neurochem 56 1991 330 338
38. H. Kamada, T. Saito, and S. Hatta Alterations of tubulin function caused by chronic antidepressant treatment in rat brain Cell Mol Neurobiol 19 1999 109 117
39. S. Avissar, and G. Schreiber The involvement of G proteins in the pathogenesis and treatment of affective disorders Biol Psychiatry 31 1992 435 459 [Ziskind-Somerfeld Award Paper]
40. S. Avissar, and G. Schreiber Interaction of antibipolar and antidepressant treatments with receptor-coupled G proteins Pharmacopsychiatry 25 1992 44 50 [Anna Monika Award Paper]
41. 35S]-GTP gamma S binding in rat brain regions Neuropharmacology 42 2002 1031 1038
42. 35S]-GTP gamma S autoradiography Br J Pharmacol 135 2002 1115 1122
43. F. Sulser Antidepressant treatments and regulation of norepinephrine-receptor coupled adenylyl cyclase systems in brain Adv Biochem Psychopharmacol 39 1984 249 261
44. R.J. Donati, C. Thukral, and M.M. Rasenick Chronic treatment of C6 glioma cells with antidepressant drugs results in a redistribution of Gs Mol Pharmacol 59 2001 1426 1432
45. I.A. Prior, A. Harding, J. Yan, J. Sluimer, R.G. Parton, and J.F. Hancock GTP-dependent segregation of H-ras from lipid rafts is required for biological activity Nat Cell Biol 3 2001 368 375
46. R.J. Donati, and M.M. Rasenick Chronic antidepressant treatment prevents accumulation of Gs-alpha in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts) Neuropsychopharmacology 30 2005 1238 1245
47. T. Kobayashi, K. Washiyama, and K. Ikeda Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine Br J Pharmacol 138 2003 1119 1128
48. T. Kobayashi, K. Washiyama, and K. Ikeda Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs Neuropsychopharmacology 29 2004 1841 1851
49. F. Lee, P. Mitchell, and C. Vivero Exclusion of close linkage of bipolar disorder to the Gs-alpha subunit gene in nine Australian pedigrees J Affect Disord 32 1994 187 195
50. A. Ram, F. Guedj, and A. Cravchik No abnormality in the gene for the G protein stimulatory alpha subunit in patients with bipolar disorder Arch Gen Psychiatry 54 Jan 1997 44 48
51. P. Zill, T.C. Baghai, and P. Zwanzger Association analysis of a polymorphism in the G-protein stimulatory alpha subunit in patients with major depression Am J Med Genet 114 2002 530 532
52. W.H. Berrettini, J. Vuoristo, T.N. Ferraro, R.J. Buono, D. Wildenauer, and L. Ala-Kokko Human G(olf) gene polymorphism and vulnerability to bipolar disorder Psychiatr Genet 8 1998 235 238
53. P. Zill, R. Engel, and T.C. Baghai Analysis of polymorphisms in the olfactory G-protein Golf in major depression Psychiatr Genet 12 2002 17 22
54. P. Zill, T.C. Baghai, and P. Zwanzger Evidence for an association between a G protein beta3-gene variant with depression and response to antidepressant treatment Neuroreport 11 2000 1893 1897
55. M. Willeit, N. Praschak-Rieder, and P. Zill C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder Biol Psychiatry 54 2003 682 686
56. A. Serretti, C. Lorenzi, and C. Cusin SSRIs antidepressant activity is influenced by G beta 3 variants Eur Neuropsychopharmacol 13 2003 117 122
57. H.J. Lee, J.H. Cha, and B.J. Ham Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders Pharmacogenomics J 4 2004 29 33
58. P.R. Joyce, R.T. Mulder, and S.E. Luty Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline Int J Neuropsychopharmacol 6 2003 339 346
59. C. Johansson, M. Willeit, and L. Aron Seasonal affective disorder and the G-protein beta-3-subunit C825T polymorphism Biol Psychiatry 55 2004 317 319
60. C.N. Lin, S.J. Tsai, and C.J. Hong Association analysis of a functional G protein beta3 subunit gene polymorphism (C825T) in mood disorders Neuropsychobiology 44 2001 118 121
61. H. Kunugi, T. Kato, R. Fukuda, M. Tatsumi, T. Sakai, and S. Nanko Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders J Neural Transm 109 2002 213 218
62. J.L. Benovic, F. Mayor, R.L. Somers, M.G. Caron, and R.J. Lefkowitz Light-dependent phosphorylation of rhodopsin by beta-adrenergic receptor kinase Nature 321 1986 869 872
63. R.J. Lefkowitz, W.P. Hausdorff, and M.G. Caron Role of phosphorylation in desensitization of the beta-adrenoceptor Trends Pharmacol Sci 11 1990 190 194
64. J.A. Pitcher, N.J. Freedman, and R.J. Lefkowitz G protein-coupled receptor kinases Annu Rev Biochem 67 1998 653 692
65. E.R. Weiss, D. Raman, and S. Shirakawa The cloning of GRK7, a candidate cone opsin kinase, from cone- and rod-dominant mammalian retinas Mol Vis 4 1998 27 35
66. K. Palczewski GTP-binding-protein-coupled receptor kinases-two mechanistic models Eur J Biochem 248 1997 261 269
67. T. Metaye, H. Gibelin, R. Perdrisot, and J.L. Kraimps Pathophysiological roles of G-protein-coupled receptor kinases Cell Signal 17 2005 917 928
68. A.B. Niculescu, D.S. Segal, and R. Kuczenski Identifying a serious of candidate genes for mania and psychosis: a convergent functional genomics approach Physiol Genomics 9 2000 83 91
69. T.B. Barrett, R.L. Hauger, and J.L. Kennedy Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder Mol Psychiatry 8 2003 546 547
70. J.A. Garcia-Sevilla, P.V. Escriba, and A. Ozaita Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides J Neurochem 72 1999 282 291
71. M. Grange-Midroit, J.A. Garcia-Sevilla, M. Ferrer-Alcon, R. La Harpe, P. Huguelet, and J. Guimon Regulation of GRK 2 and 6, beta-arrestin-2 and associated proteins in the prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression Brain Res Mol Brain Res 111 2003 31 41
72. A. Miralles, V.J. Asensio, and J.A. Garcia-Sevilla Acute treatment with the cyclic antidepressant desipramine, but not fluoxetine, increases membrane-associated G protein-coupled receptor kinases 2/3 in rat brain Neuropharmacology 43 2002 1249 1257
73. J.A. Garcia-Sevilla, P. Ventayol, and V. Perez Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment Neuropsychopharmacology 29 2004 580 588
74. J.P. Stephen, and R.J. Lefkowitz Arresting developments in heptahelical receptor signaling and regulation Trends Cell Biol 12 2002 130 138
75. M.J. Lohse, J.L. Benovic, J. Codina, M.G. Caron, and R.J. Lefkowitz Beta-arrestin: a protein that regulates beta-adrenergic receptor function Science 248 1990 1547 1550
76. R.J. Lefkowitz Historical review: a brief history and personal retrospective of seven-transmembrane receptors Trends Pharmacol Sci 25 2004 413 422
77. R.R. Gainetdinov, R.T. Premont, L.M. Bohn, R.J. Lefkowitz, and M.G. Caron Desensitization of G protein-coupled receptors and neuronal functions Annu Rev Neurosci 27 2004 107 144
78. J.P. Stephen, and R.J. Lefkowitz Arresting developments in heptahelical receptor signaling and regulation Trends Cell Biol 12 2002 130 138
79. L.M. Luttrell, and R.J. Lefkowitz The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals J Cell Sci 115 2002 455 465
80. L.P. Kristen, and R.J. Lefkowitz Classical and new roles of beta-arrestin in the regulation of G-protein-coupled receptors Nat Rev 2 2001 727 730
81. O.B. Goodman Jr., J.G. Krupnick, and F. Santini Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor Nature 383 1996 447 450
82. S.A. Laporte, R.H. Oakley, and J. Zhang The beta2-adrenergic receptor/beta-arrestin complex recruits the clathrin adaptor AP-2 during endocytosis Proc Natl Acad Sci U S A 96 1999 3712 3717
83. 2- adrenergic receptor J Biol Chem 12 1998 6976 6981
84. 2-adrenergic receptor resensitization J Biol Chem 272 1997 27,005 27,014
85. R.H. Oakley, S.A. Laporte, J.A. Holt, L.S. Barak, and M.G. Caron Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization J Biol Chem 274 1999 32,248 32,257
86. H.J. Freedman, and I.J. Lefkowitz Desensitization of G protein-coupled receptors Rec Prog Horm Res 51 1996 319 351
87. G. Parruti, F. Peracchia, and M. Sallese Molecular analysis of human beta-arrestin-1: cloning, tissue distribution, and regulation of expression J Biol Chem 268 1993 9753 9761
88. S. Avissar, A. Matuzany-Ruban, K. Tzukert, and G. Schreiber Beta-arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain Am J Psychiatry 161 2004 2066 2072
89. A. Matuzany-Ruban, S. Avissar, and G. Schreiber Dynamics of beta-arrestin1 protein and mRNA levels elevation by antidepressants in mononuclear leukocytes of patients with depression J Affect Disord 88 2005 307 312
90. L.M. Luttrell, S.S. Ferguson, and Y. Daaka Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes Science 283 1999 655 661
91. P.H. McDonald, C.W. Chow, and W.E. Miller Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3 Science 290 2000 1574 1577
92. L.M. Luttrell, F.L. Roudabush, and E.W. Choy Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds Proc Natl Acad Sci 98 2001 2449 2454
93. Y. Dwivedi, H.S. Rizavi, R.C. Roberts, R.C. Conley, C.A. Tamminga, and G.N. Pandey Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects J Neurochem 77 2001 916 928
94. G. Mercier, A.M. Lennon, and B. Renouf MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes J Mol Neurosci 24 2004 207 216
95. G. Schreiber, S. Avissar, A. Danon, and R.H. Belmaker Hyperfunctional G proteins in mononuclear leukocytes of patients with mania Biol Psychiatry 29 1991 273 280
96. C.G. Hahn, Umapathy, H.Y. Wang, R. Koneru, D.F. Levinson, and E. Friedman Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients J Psychiatr Res 39 2005 355 363
97. S. Avissar, Y. Nechamkin, L. Barki-Harrington, and G. Schreiber Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent J Affect Disord 43 1997 85 93
98. S. Avissar, Y. Nechamkin, G. Roitman, and G. Schreiber Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression Am J Psychiatry 154 1997 211 217
99. S. Avissar, Y. Nechamkin, G. Roitman, and G. Schreiber Dynamics of ECT normalization of low G protein function and immunoreactivity in mononuclear leukocytes of patients with major depression Am J Psychiatry 155 1998 666 671
100. F. Karege, P. Bovier, and R. Stepanian Change in platelets GTP-binding proteins Hum Psychopharmacol 11 1996 115 121
101. S. Avissar, I. Barki-Harrington, Y. Nechamkin, and G. Schreiber Reduced beta-adrenergic receptor-coupled Gs protein function and Gs-alpha immunoreactivity in MNL of patients with depression Biol Psychiatry 39 1996 755 760
102. P.B. Mitchell, H.K. Manji, and G. Chen High levels of Gs-alpha in platelets of euthymic patients with bipolar affective disorder Am J Psychiatry 154 1997 218 223
103. S. Avissar, G. Schreiber, and G. Lam The effects of seasons and light therapy on G proteins levels in mononuclear leukocytes of patients with seasonal affective disorder Arch Gen Psychiatry 56 1999 178 183
104. S. Avissar, and G. Schreiber Antidepressant and antibipolar treatments' effects on receptor-coupled G proteins measures in lymphocytes of patients with mood disorders Neuropsychopharmacology 10 1994 170S
105. J.P. Corradi, V. Robbins, and A.K. Hagan Alternative transcripts and evidence of imprinting of GNAL on 18p11.2 Mol Psychiatry 10 2005 1017 1025
106. M.R.S. Manley Diagnosis in psychiatry: examination of the psychiatric patient B.J. Sadock V.A. Sadock Comprehensive textbook of Psychiatry 2000 Lippincott Williams & Wilkins PA, USA 652 665
107. B.J. Carroll Dexamethasone suppression test: a review of contemporary confusion J Clin Psychol 46 1985 13 20
108. W. Coryell, and M. Schlesser The dexamethasone suppression test and suicide prediction Am J Psychiatry 158 2001 748 753
109. A.D. Sperber, A.Y. Rotem, A. Fish, G. Roitman, G. Schreiber, and S. Avissar G protein levels and function as an objective measure of depression in patients with functional bowel disorders Int J Colorectal Dis 15 2000 218 224